Alpha Crest Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $571,340 - $674,120	-6,954 Reduced 29.95%	16,264 $1.38 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $2.39 Million - $2.9 Million	-33,387 Reduced 58.98%	23,218 $1.92 Million
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $2.5 Million - $3.12 Million	33,629 Added 146.37%	56,605 $4.36 Million
Q4 2021 Feb 09, 2022	SELL	$71.72 - $91.47 $119,413 - $152,297	-1,665 Reduced 6.76%	22,976 $2.03 Million
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $1.28 Million - $1.46 Million	17,079 Added 225.85%	24,641 $1.91 Million
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $3.5 Million - $3.93 Million	-46,348 Reduced 85.97%	7,562 $631,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $1.63 Million - $1.98 Million	21,806 Added 67.92%	53,910 $4.07 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $1.16 Million - $1.44 Million	16,017 Added 99.56%	32,104 $2.82 Million
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $1.01 Million - $1.85 Million	14,085 Added 703.55%	16,087 $1.22 Million
Q2 2020 Aug 12, 2020	SELL	$79.55 - $124.22 $304,756 - $475,886	-3,831 Reduced 65.68%	2,002 $247,000
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $256,361 - $347,885	-3,592 Reduced 38.11%	5,833 $493,000
Q4 2019 Feb 12, 2020	SELL	$64.27 - $86.37 $1.16 Million - $1.56 Million	-18,069 Reduced 65.72%	9,425 $797,000
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $206,985 - $261,372	-3,071 Reduced 10.05%	27,494 $1.85 Million
Q2 2019 Aug 12, 2019	BUY	$80.35 - $93.9 $1.37 Million - $1.6 Million	17,089 Added 126.81%	30,565 $2.62 Million
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $590,831 - $692,016	7,017 Added 108.64%	13,476 $1.2 Million
Q4 2018 Feb 11, 2019	BUY	$80.14 - $106.07 $517,624 - $685,106	6,459 New	6,459 $550,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account